Little is known about the risk factors of hospitalization for atopic dermatitis (AD).
Objectives
We sought to determine associations of hospitalization for AD in the United States.
Methods
Data were analyzed from the 2002 to 2012 National Inpatient Sample. Atopic dermatitis hospitalizations were compared with controls, which included all hospitalizations without any diagnosis of AD excluding normal pregnancy/delivery, yielding a representative cohort of US hospitalizations.
Results
Both adults and children, who were admitted for AD or eczema, were more likely to have nonwhite race/ethnicity, lowest-quartile annual household income, Medicaid or no insurance, and fewer chronic conditions. Increased cost of care and prolonged length of stay were also associated with nonwhite race/ethnicities, lowest-quartile annual household income, Medicaid or no insurance, and having a higher number of chronic conditions.
Conclusions
There are significant racial/ethnic and socioeconomic differences between patients hospitalized with AD versus without it, suggesting that there may be racial/ethnic and/or health care disparities in AD.
Get full access to this article
View all access options for this article.
References
1.
SilverbergJI. Health care utilization, patient costs, and access to care in US adults with eczema: a population-based study. JAMA Dermatol, 2015; 151(7):743–752.
2.
NarlaS, HsuDY, ThyssenJP, et al.Inpatient financial burden of atopic dermatitis in the United States. J Invest Dermatol, 2017; 137:1461–1467.
3.
ShawTE, CurrieGP, KoudelkaCW, et al.Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol, 2011; 131(1):67–73.
4.
SilverbergJI, HanifinJM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol, 2013; 132(5):1132–1138.
5.
SilverbergJI, PallerAS. Association between eczema and stature in 9 US population-based studies. JAMA Dermatol, 2015; 151(4):401–409.
6.
SilverbergJI, SimpsonEL. Predictors of pediatric eczema severity in the United States: a population-based study. J Invest Dermatol, 2012; 132:S44.
7.
HoriiKA, SimonSD, LiuDY, et al.Atopic dermatitis in children in the United States, 1997–2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics, 2007; 120(3):e527–e534.
8.
VachiramonV, TeyHL, ThompsonAE, et al.Atopic dermatitis in African American children: addressing unmet needs of a common disease. Pediatr Dermatol, 2012; 29(4):395–402.
9.
Ben-GashirMA, HayRJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol, 2002; 147(5):920–925.
10.
BoanAD, FengWW, OvbiageleB, et al.Persistent racial disparity in stroke hospitalization and economic impact in young adults in the buckle of stroke belt. Stroke, 2014; 45(7):1932–1938.
11.
Mochari-GreenbergerH, MoscaL. Racial/ethnic differences in medication uptake and clinical outcomes among hospitalized cardiovascular patients with hypertension and diabetes. Am J Hypertens, 2015; 28(1):106–112.
12.
CurtisLM, WolfMS, WeissKB, et al.The impact of health literacy and socioeconomic status on asthma disparities. J Asthma, 2012; 49(2):178–183.
13.
IwaneMK, ChavesSS, SzilagyiPG, et al.Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties—2002–2009. Am J Epidemiol, 2013; 177(7):656–665.
14.
HsuD, BrievaJ, SilverbergJI. Costs of care for hospitalization for pemphigus in the United States. JAMA Dermatol, 2016; 152(6):645–654.
15.
HsuDY, GordonK, SilverbergJI. The inpatient burden of psoriasis in the United States. J Am Acad Dermatol, 2016; 75(1):33–41.
16.
AbokwidirM, DavisSA, FleischerAB, et al.Use of the emergency department for dermatologic care in the United States by ethnic group. J Dermatolog Treat, 2015; 26(4):392–394.
BenjaminiY, HochbergY. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol, 1995; 57:289–300.
20.
SilverbergJI, HanifinJ, SimpsonEL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol, 2013; 133(7):1752–1759.
21.
SilverbergJI, SimpsonEL. Associations of childhood eczema severity: a US population-based study. Dermatitis, 2014; 25(3):107–114.
22.
NeighborsHW, JacksonJS. Barriers to medical care among adult blacks: what happens to the uninsured?. J Natl Med Assoc, 1987; 79(5):489–493.
23.
ResneckJS Jr, IsensteinA, KimballAB. Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol, 2006; 55(6):1084–1088.
24.
EllisCN, DrakeLA, PrendergastMM, et al.Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol, 2002; 46(3):361–370.
25.
SilverbergJI. Racial and ethnic disparities in atopic dermatitis. Curr Dermatol Rep, 2015; 4(1):44–48.
26.
RenZ, HsuDY, BrievaJ, et al.Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.Br J Dermatol, 2017; 176(1):87–99.
27.
SchramME, TedjaAM, SpijkerR, et al.Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol, 2010; 162(5):964–973.
28.
KabashimaK, OtsukaA, NomuraT. Linking air pollution to atopic dermatitis. Nat Immunol, 2016; 18(1):5–6.
29.
KathuriaP, SilverbergJI. Association of pollution and climate with atopic eczema in US children. Pediatr Allergy Immunol, 2016; 27(5):478–485.
30.
HsuDY, DalalP, SableKA, et al.Validation of international classification of disease ninth revision codes for atopic dermatitis. Allergy, 2017; 72:1091–1095.
